Yizhou Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yizhou Zhu has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Kelvin Wai Kwok Yeung
The University of Hong Kong
5 shared publications - Shuilin Wu
School of Materials Science and Engineering, Peking University, Beijing, 100871, China
4 shared publications - Yiming Xiang
Hubei Key Laboratory of Medical Information Analysis and Tumor Diagnosis & Treatment, Key Laboratory of Cognitive Science, College of Biomedical Engineering, South-Central Minzu University, Wuhan, 430074, China
4 shared publications Chaofeng Wang
School of Life Science and Health Engineering, Hebei University of Technology, Tianjin, 300401, China
3 shared publicationsCongyang Mao
Department of Orthopaedics & Traumatology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, 999077, China
3 shared publicationsJun Wu
Department of Orthopaedics & Traumatology Li Ka Shing Faculty of Medicine The University of Hong Kong Pokfulam Hong Kong 999077 China
3 shared publications
Latest Publications
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 66, 876-921
Emerging bioactive microneedle platforms for disease management: From cutaneous disorders to systemic therapeutics
- 1 December 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 66, 876-921
Open AccessEmerging bioactive microneedle platforms for disease management: From cutaneous disorders to systemic therapeutics
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 66, 623-637
Exosomes delivering a high-throughput-screened RNA polymerase inhibitor for highly effective therapy of multidrug-resistant bacterial infected pneumonia
Bacterial pneumonia remains a primary global health threat, necessitating the development of novel therapeutic strategies to overcome escalating antibiotic resistance. In this study, we identified a highly active bacterial RNAP inhibitor, the repurposed semi-synthetic anthracycline hydrochloride Epirubicin (EPI), via the in silico high-throughput screening of a commercial library containing 16,563 small molecules. We identified EPI as a potent multi-target antibacterial agent. Alongside its intrinsic DNA intercalation properties, EPI heavily interferes with RNAP by targeting conserved catalytic residues (LYS838 and ASP1003), destabilizing the RNAP structure through a mechanism distinct from rifampicin. In vitro, EPI (8 μg/mL) achieved 99% eradication of S. aureus and multidrug-resistant (MDR) E. coli within 12 h by disrupting carbohydrate metabolism and ATP synthesis. To enhance clinical efficacy, EPI was encapsulated in stem cell-derived exosomes (Exo/EPI). In murine pneumonia models, the Exo/EPI nanoplatform cleared 99% of bacteria within 12 h. Furthermore, the platform rapidly attenuated infection-induced pulmonary inflammation, evidenced by a marked reduction in inflammatory cell infiltration, while significantly accelerating structural lung tissue repair and preventing cellular apoptosis via organized collagen deposition. This integrated strategy of computational discovery and exosomes delivery provides a blueprint for developing multifunctional antimicrobials against MDR infections.
- 1 December 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 66, 623-637
Open AccessExosomes delivering a high-throughput-screened RNA polymerase inhibitor for highly effective therapy of multidrug-resistant bacterial infected pneumonia
Bacterial pneumonia remains a primary global health threat, necessitating the development of novel therapeutic strategies to overcome escalating antibiotic resistance. In this study, we identified a highly active bacterial RNAP inhibitor, the repurposed semi-synthetic anthracycline hydrochloride Epirubicin (EPI), via the in silico high-throughput screening of a commercial library containing 16,563 small molecules. We identified EPI as a potent multi-target antibacterial agent. Alongside its intrinsic DNA intercalation properties, EPI heavily interferes with RNAP by targeting conserved catalytic residues (LYS838 and ASP1003), destabilizing the RNAP structure through a mechanism distinct from rifampicin. In vitro, EPI (8 μg/mL) achieved 99% eradication of S. aureus and multidrug-resistant (MDR) E. coli within 12 h by disrupting carbohydrate metabolism and ATP synthesis. To enhance clinical efficacy, EPI was encapsulated in stem cell-derived exosomes (Exo/EPI). In murine pneumonia models, the Exo/EPI nanoplatform cleared 99% of bacteria within 12 h. Furthermore, the platform rapidly attenuated infection-induced pulmonary inflammation, evidenced by a marked reduction in inflammatory cell infiltration, while significantly accelerating structural lung tissue repair and preventing cellular apoptosis via organized collagen deposition. This integrated strategy of computational discovery and exosomes delivery provides a blueprint for developing multifunctional antimicrobials against MDR infections.
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Nano TransMed
Naturally Derived Bioactive Regulators of Bone Homeostasis: Cellular Mechanisms and Clinical Prospects
- 1 November 2026
- Published by KEAI Publishing in Nano TransMed
Open AccessNaturally Derived Bioactive Regulators of Bone Homeostasis: Cellular Mechanisms and Clinical Prospects
- Open Access
- 15 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (61)
Electronic Chip‐Mimetic Medical Implants for Controllable Sonothermal Treatments
The sterility and controllable biological functionalities of implantable medical devices determine their lifespan, safety, and therapeutic efficacy. Inspired by the thermal effect of working electronic chips, which consist of various heterostructures, we have developed an electronic chip‐mimetic sonothermal platform through constructing metal‐semiconductor heterogeneous interface. Through magnetron sputtering on the surface of the sandblasted/acid‐etched pretreated titanium (pTi), we find that semiconductor coatings (TiO 2 , Si, ZnO, and Te) endow pTi with different in situ sonothermal effects (ΔT > 18°C, 15 min) under ultrasound (US) irradiation, whereas conductor coatings do not. The sonothermal mechanism of pTi‐semiconductor is associated with US‐activated electron and phonon transport within the heterogeneous interface of implants, which is determined by the electrical and phonon characteristics of pTi‐semiconductor, including their matching degree, thermal conductivity, defected structure, and type of semiconductor. Clinical titanium screws were introduced with defected structure in oxygen layer (TiO 2‐x ) and bone‐derived whitlockite, which shows great sonothermal/sonodynamic effects for efficient elimination of biofilm infection and improved osseointegration. In addition, the prepared NiTi‐TiO 2‐x guidewire enables rapid thrombolysis (30 min) in the deep vein thrombosis of beagles after 10 min of sonothermal/urokinase treatment. The electronic chip‐mimetic sonothermal platform provides a promising and widespread clinical application prospect.
- 15 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (61)
Open AccessElectronic Chip‐Mimetic Medical Implants for Controllable Sonothermal Treatments
The sterility and controllable biological functionalities of implantable medical devices determine their lifespan, safety, and therapeutic efficacy. Inspired by the thermal effect of working electronic chips, which consist of various heterostructures, we have developed an electronic chip‐mimetic sonothermal platform through constructing metal‐semiconductor heterogeneous interface. Through magnetron sputtering on the surface of the sandblasted/acid‐etched pretreated titanium (pTi), we find that semiconductor coatings (TiO 2 , Si, ZnO, and Te) endow pTi with different in situ sonothermal effects (ΔT > 18°C, 15 min) under ultrasound (US) irradiation, whereas conductor coatings do not. The sonothermal mechanism of pTi‐semiconductor is associated with US‐activated electron and phonon transport within the heterogeneous interface of implants, which is determined by the electrical and phonon characteristics of pTi‐semiconductor, including their matching degree, thermal conductivity, defected structure, and type of semiconductor. Clinical titanium screws were introduced with defected structure in oxygen layer (TiO 2‐x ) and bone‐derived whitlockite, which shows great sonothermal/sonodynamic effects for efficient elimination of biofilm infection and improved osseointegration. In addition, the prepared NiTi‐TiO 2‐x guidewire enables rapid thrombolysis (30 min) in the deep vein thrombosis of beagles after 10 min of sonothermal/urokinase treatment. The electronic chip‐mimetic sonothermal platform provides a promising and widespread clinical application prospect.
- Open Access
- 2 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Bioengineered ROS-tolerant probiotic reshapes gut microbiota-host axis to ameliorate type 2 diabetes in male mice
The pandemic-scale progression of type 2 diabetes mellitus (T2DM) necessitates innovative interventions targeting the pathogenic triad of insulin resistance, dysregulation of lipid metabolism, and gut microbiome dysbiosis. Here, we report a synthetically bioengineered probiotic consortium (REcN-F/Ca) developed through directed metabolic adaptations of Escherichia coli Nissle 1917 (EcN) under iterative hydrogen peroxide selection, subsequently functionalized with fructooligosaccharide-calcium carbonate composites. REcN-F/Ca exhibits enhanced reactive oxygen species tolerance through upregulated antioxidant enzymes and hydrogen sulfide-mediated redox balancing, alongside improved gastrointestinal survivability. In high-fat diet-induced obese male mice, REcN-F/Ca restores gut microbiota diversity, enriches butyrogenic taxa (Lachnospiraceae and Blautia), and rescues short-chain fatty acids depletion. Transcriptomic profiling reveals PPAR signaling activation, driving lipid metabolism and suppressing adipose inflammation. These effects translate to systemic metabolic improvements with attenuated weight gain (−25.4%), restored glucose homeostasis, and reduced insulin resistance (HOMA-IR: −73.2%) in the obesity and T2DM murine model. Our findings establish REcN-F/Ca as a synthetically engineered probiotic that simultaneously corrects intestinal ecological perturbations and reverses host metabolic dysfunction, proposing a paradigm for metabolic syndrome management.
- 2 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessBioengineered ROS-tolerant probiotic reshapes gut microbiota-host axis to ameliorate type 2 diabetes in male mice
The pandemic-scale progression of type 2 diabetes mellitus (T2DM) necessitates innovative interventions targeting the pathogenic triad of insulin resistance, dysregulation of lipid metabolism, and gut microbiome dysbiosis. Here, we report a synthetically bioengineered probiotic consortium (REcN-F/Ca) developed through directed metabolic adaptations of Escherichia coli Nissle 1917 (EcN) under iterative hydrogen peroxide selection, subsequently functionalized with fructooligosaccharide-calcium carbonate composites. REcN-F/Ca exhibits enhanced reactive oxygen species tolerance through upregulated antioxidant enzymes and hydrogen sulfide-mediated redox balancing, alongside improved gastrointestinal survivability. In high-fat diet-induced obese male mice, REcN-F/Ca restores gut microbiota diversity, enriches butyrogenic taxa (Lachnospiraceae and Blautia), and rescues short-chain fatty acids depletion. Transcriptomic profiling reveals PPAR signaling activation, driving lipid metabolism and suppressing adipose inflammation. These effects translate to systemic metabolic improvements with attenuated weight gain (−25.4%), restored glucose homeostasis, and reduced insulin resistance (HOMA-IR: −73.2%) in the obesity and T2DM murine model. Our findings establish REcN-F/Ca as a synthetically engineered probiotic that simultaneously corrects intestinal ecological perturbations and reverses host metabolic dysfunction, proposing a paradigm for metabolic syndrome management.
- 3 January 2025
- Published by American Chemical Society (ACS) in ACS Applied Electronic Materials
- Vol. 7 (1) , 313-321
Mechanically Robust and Ultrasensitive Natural Rubber/PEDOT:PSS Foam for Piezoresistive Sensors and Motion Monitoring
- 3 January 2025
- Published by American Chemical Society (ACS) in ACS Applied Electronic Materials
- Vol. 7 (1) , 313-321
Mechanically Robust and Ultrasensitive Natural Rubber/PEDOT:PSS Foam for Piezoresistive Sensors and Motion Monitoring
- Open Access
- 4 October 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (46)
Photocurrent‐Directed Immunoregulation Accelerates Osseointegration through Activating Calcium Influx in Macrophages
Early osteoimmune microenvironment disorder at the interface between bone and implant can lead to implant loosening, which prolongs patient convalescence, exacerbates postoperative complications, and potentially results in implant failure. The timely regulation of macrophages primarily orchestrates the entire long‐term regeneration process. Here, it is proposed to precisely direct macrophage polarization using localized photoelectrical signals generated by an excitable surface in response to remote stimulation via near‐infrared light (NIR). The photocurrent generated from the n–n heterojunction between calcium titanate (CaTiO3) and defective titanium dioxide (TiO2‐Vo) on the excitable surface can accurately direct macrophage polarization, suppressing acute inflammation at the early stage of post‐implantation and establishing a favorable osteoimmune microenvironment that promotes bone‐to‐implant integration. Mechanistic study reveals that photoelectric signals initiate increased calcium influx via voltage‐gated calcium ion channels, subsequently modulating calcium/calmodulin‐dependent protein kinase kinase 2 (Camkk2) and calcium/calmodulin‐dependent protein kinase I (Camk1) expression to regulate macrophage polarization. This optimization of the osteoimmune microenvironment results in enhanced mesenchymal stem cells (MSCs) recruitment and osteogenesis, ultimately accelerating bone‐to‐implant integration within 14 days post‐implantation. This research presents a novel method for adjusting in vivo spatiotemporal immune responses through the use of noninvasive and externally‐controlled targeted stimulations.
- 4 October 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (46)
Open AccessPhotocurrent‐Directed Immunoregulation Accelerates Osseointegration through Activating Calcium Influx in Macrophages
Early osteoimmune microenvironment disorder at the interface between bone and implant can lead to implant loosening, which prolongs patient convalescence, exacerbates postoperative complications, and potentially results in implant failure. The timely regulation of macrophages primarily orchestrates the entire long‐term regeneration process. Here, it is proposed to precisely direct macrophage polarization using localized photoelectrical signals generated by an excitable surface in response to remote stimulation via near‐infrared light (NIR). The photocurrent generated from the n–n heterojunction between calcium titanate (CaTiO3) and defective titanium dioxide (TiO2‐Vo) on the excitable surface can accurately direct macrophage polarization, suppressing acute inflammation at the early stage of post‐implantation and establishing a favorable osteoimmune microenvironment that promotes bone‐to‐implant integration. Mechanistic study reveals that photoelectric signals initiate increased calcium influx via voltage‐gated calcium ion channels, subsequently modulating calcium/calmodulin‐dependent protein kinase kinase 2 (Camkk2) and calcium/calmodulin‐dependent protein kinase I (Camk1) expression to regulate macrophage polarization. This optimization of the osteoimmune microenvironment results in enhanced mesenchymal stem cells (MSCs) recruitment and osteogenesis, ultimately accelerating bone‐to‐implant integration within 14 days post‐implantation. This research presents a novel method for adjusting in vivo spatiotemporal immune responses through the use of noninvasive and externally‐controlled targeted stimulations.
- Top Cited Papers
- 10 March 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (10) , eadf0854
Ultrasound-triggered interfacial engineering-based microneedle for bacterial infection acne treatment
Acne is an inflammatory skin disease mainly caused by Propionibacterium acnes , which can cause local inflammatory reactions and develop into chronic inflammatory diseases in severe cases. To avoid the use of antibiotics and to effectively treat the site of acne, we report a sodium hyaluronate microneedle patch that mediates the transdermal delivery of ultrasound-responsive nanoparticles for the effective treatment of acne. The patch contains nanoparticles formed by zinc porphyrin–based metal-organic framework and zinc oxide (ZnTCPP@ZnO). We demonstrated activated oxygen-mediated killing of P. acnes with an antibacterial efficiency of 99.73% under 15 min of ultrasound irradiation, resulting in a decrease in levels of acne-related factors, including tumor necrosis factor–α, interleukins, and matrix metalloproteinases. The zinc ions up-regulated DNA replication–related genes, promoting the proliferation of fibroblasts and, consequently, skin repair. This research leads to a highly effective strategy for acne treatment through the interface engineering of ultrasound response.
- 10 March 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (10) , eadf0854
Top Cited PapersUltrasound-triggered interfacial engineering-based microneedle for bacterial infection acne treatment
Acne is an inflammatory skin disease mainly caused by Propionibacterium acnes , which can cause local inflammatory reactions and develop into chronic inflammatory diseases in severe cases. To avoid the use of antibiotics and to effectively treat the site of acne, we report a sodium hyaluronate microneedle patch that mediates the transdermal delivery of ultrasound-responsive nanoparticles for the effective treatment of acne. The patch contains nanoparticles formed by zinc porphyrin–based metal-organic framework and zinc oxide (ZnTCPP@ZnO). We demonstrated activated oxygen-mediated killing of P. acnes with an antibacterial efficiency of 99.73% under 15 min of ultrasound irradiation, resulting in a decrease in levels of acne-related factors, including tumor necrosis factor–α, interleukins, and matrix metalloproteinases. The zinc ions up-regulated DNA replication–related genes, promoting the proliferation of fibroblasts and, consequently, skin repair. This research leads to a highly effective strategy for acne treatment through the interface engineering of ultrasound response.
- Top Cited PapersOpen Access
- 2 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (14) , eabf6654
Regulation of macrophage polarization through surface topography design to facilitate implant-to-bone osteointegration
Scale-dependent osteo-immune regulation induced by specific TiO 2 nanostructure accelerates implant-to-bone integration.
- 2 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (14) , eabf6654
Top Cited PapersOpen AccessRegulation of macrophage polarization through surface topography design to facilitate implant-to-bone osteointegration
Scale-dependent osteo-immune regulation induced by specific TiO 2 nanostructure accelerates implant-to-bone integration.